NCK hasnt provided guidance since about april 2021 I think - covid/interest rates etc.. I think its a responsible line to take. Im not saying its a great time to buy - just not sure all fears are going to be realised.
Today
The 2H FY23 result will depend upon trading during February to April and at this point it is difficult to provide further guidance
Sept 2022 presentation
Based on the current economic uncertainty, it is difficult to provide any additional guidance for the FY23 financial year.
May 2022 presentation. However, with current lockdowns in sourcing locations and ongoing delays in shipping as a result, the extent to which revenue and ultimately profit will be recognised this financial year cannot be accurately forecast at the current time.
Feb 2022The Group’s suppliers have recently reinstated normal lead times, and this should facilitate revenue growth over the coming months. However, shipping costs and the availability of containers remains uncertain, and will be a major obstacle in the delivery of the outstanding order bank. Whilst the Group continues to expect revenue to increase materially during the second half, the costs of shipping could well impact profitability during the period.
Aug 2021Despite the buoyant trading conditions, there is a high degree of uncertainty in the current retail environment, duepotential future lockdowns, supply chain challenges caused by lockdowns in sourcing countries, and the continuingescalation of global shipping costs. Given the uncertainty, it is not possible to provide profit guidance for the Company for the first half of FY22
- Forums
- ASX - By Stock
- Ann: 1H FY23 Results Announcement
NCK hasnt provided guidance since about april 2021 I think -...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NCK (ASX) to my watchlist
(20min delay)
|
|||||
Last
$16.07 |
Change
0.020(0.12%) |
Mkt cap ! $1.369B |
Open | High | Low | Value | Volume |
$16.12 | $16.24 | $15.99 | $2.726M | 169.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 639 | $16.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.09 | 7386 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 639 | 16.000 |
2 | 640 | 15.980 |
1 | 639 | 15.970 |
1 | 2011 | 15.960 |
1 | 639 | 15.950 |
Price($) | Vol. | No. |
---|---|---|
16.100 | 639 | 1 |
16.120 | 639 | 1 |
16.130 | 639 | 1 |
16.150 | 639 | 1 |
16.180 | 1906 | 2 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
NCK (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online